Enhancing anti-tumor efficacy and immune memory by combining 3p-GPC-3 siRNA treatment with PD-1 blockade in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is associated with a high mortality rate and presents a major challenge for human health. Activation of multiple oncogenes has been reported to be strongly associated with the progression of HCC. Moreover, the immunosuppressive tumor microenvironment (TME) and the host...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Liwei, Yu, Xin, Han, Qiuju, Zhang, Xinke, Lu, Nan, Zhang, Cai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746623/
https://www.ncbi.nlm.nih.gov/pubmed/36524206
http://dx.doi.org/10.1080/2162402X.2021.2010894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746623/
https://www.ncbi.nlm.nih.gov/pubmed/36524206
http://dx.doi.org/10.1080/2162402X.2021.2010894

Ejemplares similares